{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:35:48Z","timestamp":1780083348358,"version":"3.54.0"},"reference-count":61,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2023.1647","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T12:03:00Z","timestamp":1691496180000},"source":"Crossref","is-referenced-by-count":6,"title":["Prothrombotic status in COVID\u201119 with diabetes mellitus (Review)"],"prefix":"10.3892","volume":"19","author":[{"given":"Roxana","family":"Mitroi","sequence":"first","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Padureanu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Mitrea","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Cristina","family":"Protasiewicz Timofticiuc","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Magdalena","family":"Rosu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Clenciu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Enescu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Padureanu","sequence":"additional","affiliation":[{"name":"Department of Pneumology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiberiu Stefanita","family":"Tenea Cojan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela Mihaela","family":"Vladu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Nutrition and Metabolic Diseases, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"key20230927133721_b1-BR-19-4-01647"},{"key":"key20230927133721_b2-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.4103\/jfmpc.jfmpc_709_22","article-title":"Effect of SARS-CoV-2 on glycemic control in post-COVID-19 diabetic patients","volume":"11","author":"Yadaiah","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"key20230927133721_b3-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","article-title":"Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: A two-centre descriptive study","volume":"20","author":"Carsana","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"key20230927133721_b4-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: Understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"154845","key":"key20230927133721_b5-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154845","article-title":"Thromboembolism risk among patients with diabetes\/stress hyperglycemia and COVID-19","volume":"123","author":"Calvisi","year":"2021","journal-title":"Metabolism"},{"issue":"109923","key":"key20230927133721_b6-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.109923","article-title":"Diabetes and severity of COVID-19: What is the link?","volume":"143","author":"Pitocco","year":"2020","journal-title":"Med Hypotheses"},{"key":"key20230927133721_b7-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.dsx.2020.07.015","article-title":"Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?","volume":"14","author":"Wijaya","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"792393","key":"key20230927133721_b8-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/792393","article-title":"Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus","volume":"2010","author":"van den Oever","year":"2010","journal-title":"Mediators Inflamm"},{"key":"key20230927133721_b9-BR-19-4-01647","author":"Haller"},{"key":"key20230927133721_b10-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1210\/edrv.22.1.0417","article-title":"Diabetes and endothelial dysfunction: A clinical perspective","volume":"22","author":"Calles-Escandon","year":"2001","journal-title":"Endocr Rev"},{"key":"key20230927133721_b11-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"issue":"1605","key":"key20230927133721_b12-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.3390\/life12101605","article-title":"Endothelial dysfunction in COVID-19: Potential mechanisms and possible therapeutic options","volume":"12","author":"Pelle","year":"2022","journal-title":"Life (Basel)"},{"key":"key20230927133721_b13-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: Novel insights into mechanisms and pathophysiology","volume":"112","author":"Higuchi","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"key20230927133721_b14-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.thromres.2020.08.039","article-title":"COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?","volume":"196","author":"Del Turco","year":"2020","journal-title":"Thromb Res"},{"issue":"279","key":"key20230927133721_b15-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59020279","article-title":"The significance of low magnesium levels in COVID-19 patients","volume":"59","author":"Coman","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"key20230927133721_b16-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"key20230927133721_b17-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: Challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson","year":"2019","journal-title":"Blood"},{"key":"key20230927133721_b18-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"key":"key20230927133721_b19-BR-19-4-01647","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2012.006","article-title":"Inflammation and haemostasis","volume":"22","author":"Margetic","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"73","key":"key20230927133721_b20-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00073","article-title":"Understanding inflammatory responses in the manifestation of prothrombotic phenotypes","volume":"8","author":"Chanchal","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"key20230927133721_b21-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reumae.2020.06.007","article-title":"Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes","volume":"18","author":"P\u00e1ramo","year":"2022","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"key20230927133721_b22-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/cei\/uxac055","article-title":"Increased TNF-\u03b1 production in response to IL-6 in patients with systemic inflammation without infection","volume":"209","author":"Cabrera-Rivera","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"key20230927133721_b23-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","article-title":"The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection","volume":"146","author":"Copaescu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"key20230927133721_b24-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1097\/MS9.0000000000000679","article-title":"IL1\u03b2, IL-6, and TNF-\u03b1 cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: Case-control study","volume":"85","author":"Faraj","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"issue":"104188","key":"key20230927133721_b25-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2021.104188","article-title":"Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)","volume":"137","author":"Norooznezhad","year":"2021","journal-title":"Microvasc Res"},{"key":"key20230927133721_b26-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1074\/jbc.271.2.736","article-title":"Interleukin 6 induces the expression of vascular endothelial growth factor","volume":"271","author":"Cohen","year":"1996","journal-title":"J Biol Chem"},{"issue":"742941","key":"key20230927133721_b27-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.742941","article-title":"Hyperinflammatory immune response and COVID-19: A double edged sword","volume":"12","author":"Tan","year":"2021","journal-title":"Front Immunol"},{"issue":"e3319","key":"key20230927133721_b28-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"36","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"key20230927133721_b29-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00540-018-2507-7","article-title":"Endothelium-dependent vasodilation in the cerebral arterioles of rats deteriorates during acute hyperglycemia and then is restored by reducing the glucose level","volume":"32","author":"Kito","year":"2018","journal-title":"J Anesth"},{"key":"key20230927133721_b30-BR-19-4-01647","first-page":"103","article-title":"Atherothrombosis: Role of tissue factor; link between diabetes, obesity and inflammation","volume":"45","author":"Meerarani","year":"2007","journal-title":"Indian J Exp Biol"},{"key":"key20230927133721_b31-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"E57","DOI":"10.1177\/1076029610384112","article-title":"The hemostatic system in patients with type 2 diabetes with and without cardiovascular disease","volume":"17","author":"Verkleij","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"key20230927133721_b32-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/01.cir.98.21.2241","article-title":"High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor","volume":"98","author":"Th\u00f6gersen","year":"1998","journal-title":"Circulation"},{"key":"key20230927133721_b33-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jdiacomp.2006.02.001","article-title":"High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro","volume":"21","author":"Iwasaki","year":"2007","journal-title":"J Diabetes Complications"},{"key":"key20230927133721_b34-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4239\/wjd.v12.i5.590","article-title":"Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients","volume":"12","author":"Rojas","year":"2021","journal-title":"World J Diabetes"},{"key":"key20230927133721_b35-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tem.2013.08.002","article-title":"Unlocking the biology of RAGE in diabetic microvascular complications","volume":"25","author":"Manigrasso","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"key20230927133721_b36-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.vph.2012.06.004","article-title":"The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes","volume":"57","author":"Ramasamy","year":"2012","journal-title":"Vascul Pharmacol"},{"issue":"9227","key":"key20230927133721_b37-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45798-5","article-title":"Inhibition of the receptor for advanced glycation end-products in acute respiratory distress syndrome: A randomised laboratory trial in piglets","volume":"9","author":"Audard","year":"2019","journal-title":"Sci Rep"},{"issue":"7208","key":"key20230927133721_b38-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07638-2","article-title":"RAGE inhibition reduces acute lung injury in mice","volume":"7","author":"Blondonnet","year":"2017","journal-title":"Sci Rep"},{"key":"key20230927133721_b39-BR-19-4-01647","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/diabetes.55.01.06.db05-1026","article-title":"Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand","volume":"55","author":"Vaidyula","year":"2006","journal-title":"Diabetes"},{"key":"key20230927133721_b40-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1464-5491.2007.02348.x","article-title":"Effect of acute hyperglycaemia and\/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans","volume":"25","author":"Stegenga","year":"2008","journal-title":"Diabet Med"},{"key":"key20230927133721_b41-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00125-006-0197-4","article-title":"Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus","volume":"49","author":"Dunn","year":"2006","journal-title":"Diabetologia"},{"issue":"59","key":"key20230927133721_b42-BR-19-4-01647","article-title":"Causality relationships between coagulation factors in type 2 diabetes mellitus: Path analysis approach","volume":"28","author":"Dayer","year":"2014","journal-title":"Med J Islam Repub Iran"},{"key":"key20230927133721_b43-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11892-007-0035-1","article-title":"Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation","volume":"7","author":"Boden","year":"2007","journal-title":"Curr Diab Rep"},{"key":"key20230927133721_b44-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1160\/TH14-05-0468","article-title":"The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease","volume":"112","author":"Neergaard-Petersen","year":"2014","journal-title":"Thromb Haemost"},{"key":"key20230927133721_b45-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.dsx.2019.01.049","article-title":"The importance of measurement of plasma fibrinogen level among patients with type-2 diabetes mellitus","volume":"13","author":"Abdul Razak","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"key20230927133721_b46-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.thromres.2006.10.016","article-title":"Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation","volume":"120","author":"Pieters","year":"2007","journal-title":"Thromb Res"},{"key":"key20230927133721_b47-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"key20230927133721_b48-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"100731","key":"key20230927133721_b49-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100731","article-title":"Understanding the andromeda strain-the role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness","volume":"45","author":"Mir","year":"2021","journal-title":"Blood Rev"},{"key":"key20230927133721_b50-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"key20230927133721_b51-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/jmv.26336","article-title":"Coagulation dysfunction is associated with severity of COVID-19: A meta-analysis","volume":"93","author":"Zhu","year":"2021","journal-title":"J Med Virol"},{"key":"key20230927133721_b52-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"7394378","key":"key20230927133721_b53-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7394378","article-title":"Diabetes mellitus and COVID-19: Associations and possible mechanisms","volume":"2021","author":"Li","year":"2021","journal-title":"Int J Endocrinol"},{"key":"key20230927133721_b54-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.2147\/IDR.S367012","article-title":"Elevated D-dimer and adverse in-hospital outcomes in COVID-19 patients and synergism with hyperglycemia","volume":"15","author":"Li","year":"2022","journal-title":"Infect Drug Resist"},{"key":"key20230927133721_b55-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.dsx.2020.09.035","article-title":"Relation of D-dimer levels of COVID-19 patients with diabetes mellitus","volume":"14","author":"Mishra","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"key20230927133721_b56-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"67","DOI":"10.15537\/smj.2023.44.1.20220462","article-title":"Impact of diabetes mellitus and co-morbidities on mortality in patients with COVID-19: A single-center retrospective study","volume":"44","author":"Sindi","year":"2023","journal-title":"Saudi Med J"},{"key":"key20230927133721_b57-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/rth2.12462","article-title":"Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality","volume":"5","author":"von Meijenfeldt","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"10760296211045902","key":"key20230927133721_b58-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211045902","article-title":"D-dimer level and diabetes in the COVID-19 infection","volume":"27","author":"Miri","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"key20230927133721_b59-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.3892\/br.2022.1590","article-title":"Factors associated with disease severity of COVID-19 in patients with type 2 diabetes mellitus","volume":"18","author":"Novida","year":"2022","journal-title":"Biomed Rep"},{"key":"key20230927133721_b60-BR-19-4-01647","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","article-title":"Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: A case series","volume":"396","author":"Bradley","year":"2020","journal-title":"Lancet"},{"issue":"108217","key":"key20230927133721_b61-BR-19-4-01647","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108217","article-title":"The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19","volume":"164","author":"Whyte","year":"2020","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:37:28Z","timestamp":1695811048000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2023.1647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8,8]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2023.1647","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"article-number":"65"}}